- Home
- SNGX vs PETZ Comparison
SNGX vs PETZ Comparison
Compare SNGX & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- PETZ
- Stock Information
- Founded
- SNGX 1987
- PETZ 2002
- Country
- SNGX United States
- PETZ China
- Employees
- SNGX N/A
- PETZ 17
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- PETZ Steel/Iron Ore
- Sector
- SNGX Health Care
- PETZ Industrials
- Exchange
- SNGX Nasdaq
- PETZ Nasdaq
- Market Cap
- SNGX 10.1M
- PETZ 11.3M
- IPO Year
- SNGX 1987
- PETZ 2017
- Fundamental
- Price
- SNGX $1.64
- PETZ $1.13
- Analyst Decision
- SNGX Strong Buy
- PETZ
- Analyst Count
- SNGX 1
- PETZ 0
- Target Price
- SNGX $6.00
- PETZ N/A
- AVG Volume (30 Days)
- SNGX 2.9M
- PETZ 244.6K
- Earning Date
- SNGX 11-07-2025
- PETZ 04-28-2025
- Dividend Yield
- SNGX N/A
- PETZ N/A
- EPS Growth
- SNGX N/A
- PETZ N/A
- EPS
- SNGX N/A
- PETZ 0.26
- Revenue
- SNGX N/A
- PETZ $563,726.00
- Revenue This Year
- SNGX N/A
- PETZ N/A
- Revenue Next Year
- SNGX N/A
- PETZ N/A
- P/E Ratio
- SNGX N/A
- PETZ $5.34
- Revenue Growth
- SNGX N/A
- PETZ 74664.72
- 52 Week Low
- SNGX $1.09
- PETZ $0.65
- 52 Week High
- SNGX $6.23
- PETZ $1.68
- Technical
- Relative Strength Index (RSI)
- SNGX 41.70
- PETZ 55.81
- Support Level
- SNGX $1.60
- PETZ $1.04
- Resistance Level
- SNGX $1.97
- PETZ $1.16
- Average True Range (ATR)
- SNGX 0.16
- PETZ 0.06
- MACD
- SNGX 0.06
- PETZ -0.00
- Stochastic Oscillator
- SNGX 61.63
- PETZ 59.95
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.